Wall Street Experts
ver. ZuMIgo(08/25)
Gyre Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 108
EBIT TTM (mln): 18
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
Rok finansowy |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
2 |
2 |
2 |
4 |
1 |
28 |
12 |
20 |
25 |
86 |
98 |
58 |
4 |
0 |
2 |
0 |
1 |
0 |
0 |
21 |
7 |
1 |
113 |
106 |
Przychód Δ r/r |
0.0% |
34.2% |
7.5% |
52.1% |
-68.4% |
2233.9% |
-58.0% |
73.5% |
24.8% |
242.0% |
13.9% |
-40.7% |
-93.7% |
-92.4% |
536.4% |
-77.2% |
155.1% |
-99.4% |
-100.0% |
inf% |
-65.0% |
-89.2% |
14188.4% |
-6.8% |
Marża brutto |
100.0% |
89.3% |
69.8% |
94.7% |
59.2% |
98.3% |
93.8% |
96.3% |
97.2% |
100.0% |
100.0% |
100.0% |
-80.7% |
-1815.3% |
-240.5% |
-2545.4% |
-1162.0% |
-357800.0% |
-inf% |
56.3% |
-0.6% |
-0.5% |
95.9% |
96.3% |
EBIT (mln) |
-9 |
-21 |
-20 |
-24 |
-30 |
-0 |
-32 |
-28 |
-40 |
13 |
-10 |
-8 |
-47 |
-30 |
-14 |
-20 |
-22 |
-34 |
-57 |
-57 |
-88 |
-9 |
-67 |
16 |
EBIT Δ r/r |
0.0% |
140.0% |
-4.5% |
21.6% |
22.7% |
-98.7% |
7770.3% |
-11.4% |
43.3% |
-132.5% |
-174.3% |
-16.5% |
480.2% |
-37.1% |
-53.6% |
47.9% |
6.9% |
55.0% |
69.3% |
0.2% |
53.2% |
-90.2% |
680.7% |
-124.0% |
EBIT (%) |
-513.9% |
-918.8% |
-816.3% |
-652.5% |
-2537.5% |
-1.5% |
-274.5% |
-140.1% |
-160.9% |
15.3% |
-10.0% |
-14.1% |
-1301.1% |
-10805.1% |
-788.7% |
-5117.3% |
-2143.6% |
-563700.0% |
0.0% |
-273.9% |
-1197.8% |
-1084.5% |
-59.3% |
15.3% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
-84 |
-138 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
-0 |
1 |
0 |
0 |
EBITDA (mln) |
-9 |
-21 |
-20 |
-24 |
-29 |
0 |
-31 |
-28 |
-40 |
13 |
-10 |
-1 |
-47 |
-28 |
-13 |
-17 |
-22 |
-34 |
-57 |
-57 |
-88 |
-52 |
116 |
16 |
EBITDA(%) |
-513.9% |
-918.8% |
-816.3% |
-631.9% |
-2469.5% |
1.5% |
-266.6% |
-140.1% |
-160.9% |
15.3% |
-10.0% |
-1.2% |
-1301.1% |
-10349.1% |
-732.2% |
-4246.9% |
-2143.6% |
-563700.0% |
0.0% |
-273.9% |
-1193.8% |
-6568.4% |
102.3% |
15.3% |
Podatek (mln) |
7 |
21 |
19 |
-0 |
-1 |
-3 |
-4 |
-4 |
-0 |
4 |
-2 |
-0 |
0 |
3 |
1 |
3 |
-0 |
4 |
-2 |
-1 |
-0 |
0 |
9 |
5 |
Zysk Netto (mln) |
-7 |
-21 |
-19 |
-24 |
-29 |
2 |
-28 |
-26 |
-39 |
11 |
-9 |
-7 |
-47 |
-33 |
-15 |
-17 |
-22 |
-30 |
-53 |
-56 |
-88 |
2 |
-93 |
12 |
Zysk netto Δ r/r |
0.0% |
188.6% |
-8.0% |
23.9% |
20.7% |
-107.2% |
-1439.0% |
-8.6% |
53.6% |
-127.7% |
-178.3% |
-18.0% |
567.4% |
-30.2% |
-54.7% |
14.8% |
27.2% |
39.4% |
76.0% |
5.0% |
58.3% |
-102.6% |
-4137.1% |
-113.0% |
Zysk netto (%) |
-428.8% |
-921.8% |
-789.1% |
-642.7% |
-2457.1% |
7.6% |
-242.5% |
-127.8% |
-157.2% |
12.7% |
-8.7% |
-12.1% |
-1287.0% |
-11862.9% |
-843.5% |
-4246.9% |
-2118.0% |
-500916.7% |
0.0% |
-265.1% |
-1198.3% |
289.9% |
-81.9% |
11.4% |
EPS |
-2805.22 |
-8095.27 |
-18684.97 |
-11511.93 |
-11619.85 |
-9.45 |
-149.47 |
-109.24 |
-161.39 |
39.9 |
-28.31 |
-21.95 |
-145.78 |
-101.4 |
-49.99 |
-21.76 |
-6.3 |
-2.68 |
-4.41 |
-2.9 |
-2.87 |
0.0362 |
-1.41 |
0.14 |
EPS (rozwodnione) |
-2805.22 |
-8095.27 |
-18684.97 |
-11511.93 |
-11619.85 |
-9.45 |
-149.47 |
-109.24 |
-161.39 |
37.8 |
-28.31 |
-21.95 |
-145.78 |
-101.4 |
-49.99 |
-21.76 |
-6.3 |
-2.68 |
-4.41 |
-2.9 |
-2.87 |
0.03 |
-1.41 |
0.05 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
11 |
12 |
19 |
31 |
77 |
66 |
85 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
11 |
12 |
19 |
31 |
76 |
66 |
102 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |